Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/25 16:05 | 1/28/25 | VCEL | Health | BioPrd | Biological Products, (No Diag | Siegal Jonathan | MA | O | Principa | 1 | S.d | -242 | 61.99 | 0 | -4 | 1 | D | |||||||||||||||
12/5/24 16:05 | 12/4/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Wotton Paul K | MA | D | 1 | S | -153 | 58.72 | 0 | -3 | 27 | D | ||||||||||||||||
12/3/24 16:05 | 12/2/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Hopper Jonathan Mark | MA | O | Chief Me | 1 | S.d | -587 | 58.72 | 0 | -10 | 58 | D | |||||||||||||||
11/25/24 16:05 | 11/22/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Zerbe Robert L Md | MA | D | 2 | S.dm | -431 | 57.50 | 0 | -8 | 27 | D | ||||||||||||||||
11/15/24 16:05 | 11/13/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | McLaughlin Kevin F | MA | D | 1 | S.d | -389 | 55.54 | 0 | -7 | 12 | D | ||||||||||||||||
11/15/24 16:05 | 11/13/24 | VCEL | Health | BioPrd | Biological Products, (No Diag | Colangelo Dominick | MA | DO | P,CEO | 1 | S.dm | -1,916 | 54.75 | 0 | -35 | 221 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |